A detailed history of Bvf Inc transactions in Molecular Partners Ag stock. As of the latest transaction made, Bvf Inc holds 443,221 shares of MOLN stock, worth $2.39 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
443,221
Previous 443,221 -0.0%
Holding current value
$2.39 Million
Previous $3.2 Million 29.62%
% of portfolio
0.07%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$9.99 - $20.49 $241,887 - $496,124
24,213 Added 5.78%
443,221 $8.55 Million
Q3 2021

Nov 15, 2021

BUY
$18.34 - $21.0 $7.68 Million - $8.8 Million
419,008 New
419,008 $8.27 Million

Others Institutions Holding MOLN

About MOLECULAR PARTNERS AG


  • Ticker MOLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,514,000
  • Market Cap $176M
  • Description
  • Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...
More about MOLN
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.